Pharmacokinetics of daptomycin in a patient with severe renal failure not receiving dialysis

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2898-2899

  Marchand, Sandrine ^a,b,c   Lauda, Maider ^a   Le Moal, Gwenael ^a   Gobin, Patrice ^a,c   Couet, William ^a,b,c   Roblot, France ^a,b,c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATININE; DAPTOMYCIN; LEVOFLOXACIN; RIFAMPICIN;

ACUTE HEART FAILURE; ADULT; AORTA VALVE REPLACEMENT; AREA UNDER THE CURVE; CASE REPORT; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; LIQUID CHROMATOGRAPHY; LOADING DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; FEMALE; GENTAMICINS; HUMANS; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 84877849158     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00230-13     Document Type: Letter

References (6)

1. Kim A, Suecof LA, Sutherland CA, Gao L, Kuti JL, Nicolau DP. 2008. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers. Antimicrob. Agents Chemother. 52: 3941-3946.
2. Bhavnani SM, Rubino CM, Ambrose PG, Drusano GL. 2010. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: Data from a randomized trial of patients with bacteremia and endocarditis. Clin. Infect. Dis. 50:1568-1574.
3. Patel N, Cardone K, Grabe DW, Meola S, Hoy C, Manley H, Drusano GL, Lodise TP. 2011. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis. Antimicrob. Agents Chemother. 55:1677-1683.
4. Verdier MC, Bentue-Ferrer D, Tribut O, Collet N, Revest M, Bellissant E. 2011. Determination of daptomycin in human plasma by liquid chromatography- tandem mass spectrometry. Clinical application. Clin. Chem. Lab. Med. 49:69-75.
5. Baietto L, D'Avolio A, De Rosa FG, Garazzino S, Michelazzo M, Ventimiglia G, Siccardi M, Simiele M, Sciandra M, Di Perri G. 2010. Development and validation of a simultaneous extraction procedure for HPLC-MSquantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. Anal. Bioanal. Chem. 396:791-798.
6. Cardone KE, Lodise TP, Patel N, Hoy CD, Meola S, Manley HJ, Drusano GL, Grabe DW. 2011. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis. Clin. J. Am. Soc. Nephrol. 6:1081-1088.